Pharma & Biopharma

Sagi Nahum and Dana Fuchs Telem from Orgenesis talk us through the central challenges – and solutions – in the analysis of cell and gene therapies

Geoff Winkett discusses developments in molecular spectroscopy and the growth of the biopharma market

We share some of the pieces we’ve published in the (Bio)pharma space so far this year

Merck joins forces with Agilent Technologies to develop process analytical technologies for downstream bioprocess monitoring and control

What would it mean for science as a whole if the results of a seminal Alzheimer's paper underpinning the amyloid hypothesis were fabricated?

Putting COVID-19 on a diet, native ambient MS aids drug discovery, and elucidating monoclonal antibody structure with IMS-MS…

Combining fluorescence microscopy with flow cytometry to sort cells based on visual characteristics

How ion mobility-mass spectrometry could lead to improvements in bioprocessing efficiency

Mohsin El Amrani believes 2D-LC with HRAM-MS pave the way for bioanalytical quantification of next-generation therapeutic mAbs

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.